Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH
Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of LUTS, other than urinary incontinence, associated with OAB and/or BPH.
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TAYLOR, JR. CHARLES PRICE WESTBROOK SIMON LEMPRIER THORPE ANDREW JOHN WUSTROW DAVID JUERGEN |
| description | Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of LUTS, other than urinary incontinence, associated with OAB and/or BPH. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2011039899A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2011039899A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2011039899A13</originalsourceid><addsrcrecordid>eNqNi7EKwjAYBrM4iPoOP7gqNHYxoxW1ThVa5_KbfMFCTUIS-vwq-ABOB8fdXDQXfnCAy4Mj6yPlJ6iL4Pz6OPKWmgmRdR4mUDWyMYgbanNESnR12n9HOA1iZ6i61UsxszwmrH5ciPX51B3rLYLvkQJrOOT-3u4KKYtS7ZU6yPK_6g2-xTbo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH</title><source>esp@cenet</source><creator>TAYLOR, JR. CHARLES PRICE ; WESTBROOK SIMON LEMPRIER ; THORPE ANDREW JOHN ; WUSTROW DAVID JUERGEN</creator><creatorcontrib>TAYLOR, JR. CHARLES PRICE ; WESTBROOK SIMON LEMPRIER ; THORPE ANDREW JOHN ; WUSTROW DAVID JUERGEN</creatorcontrib><description>Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of LUTS, other than urinary incontinence, associated with OAB and/or BPH.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110217&DB=EPODOC&CC=US&NR=2011039899A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110217&DB=EPODOC&CC=US&NR=2011039899A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAYLOR, JR. CHARLES PRICE</creatorcontrib><creatorcontrib>WESTBROOK SIMON LEMPRIER</creatorcontrib><creatorcontrib>THORPE ANDREW JOHN</creatorcontrib><creatorcontrib>WUSTROW DAVID JUERGEN</creatorcontrib><title>Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH</title><description>Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of LUTS, other than urinary incontinence, associated with OAB and/or BPH.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi7EKwjAYBrM4iPoOP7gqNHYxoxW1ThVa5_KbfMFCTUIS-vwq-ABOB8fdXDQXfnCAy4Mj6yPlJ6iL4Pz6OPKWmgmRdR4mUDWyMYgbanNESnR12n9HOA1iZ6i61UsxszwmrH5ciPX51B3rLYLvkQJrOOT-3u4KKYtS7ZU6yPK_6g2-xTbo</recordid><startdate>20110217</startdate><enddate>20110217</enddate><creator>TAYLOR, JR. CHARLES PRICE</creator><creator>WESTBROOK SIMON LEMPRIER</creator><creator>THORPE ANDREW JOHN</creator><creator>WUSTROW DAVID JUERGEN</creator><scope>EVB</scope></search><sort><creationdate>20110217</creationdate><title>Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH</title><author>TAYLOR, JR. CHARLES PRICE ; WESTBROOK SIMON LEMPRIER ; THORPE ANDREW JOHN ; WUSTROW DAVID JUERGEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2011039899A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TAYLOR, JR. CHARLES PRICE</creatorcontrib><creatorcontrib>WESTBROOK SIMON LEMPRIER</creatorcontrib><creatorcontrib>THORPE ANDREW JOHN</creatorcontrib><creatorcontrib>WUSTROW DAVID JUERGEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAYLOR, JR. CHARLES PRICE</au><au>WESTBROOK SIMON LEMPRIER</au><au>THORPE ANDREW JOHN</au><au>WUSTROW DAVID JUERGEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH</title><date>2011-02-17</date><risdate>2011</risdate><abstract>Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of LUTS, other than urinary incontinence, associated with OAB and/or BPH.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2011039899A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A23%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAYLOR,%20JR.%20CHARLES%20PRICE&rft.date=2011-02-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2011039899A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |